Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More
FTC Workshop Can Highlight How Brand Name Drug Companies Employ… Read More
Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious… Read More
Academic Study Underscores How Big Pharma’s Price-Gouging on Treatments for… Read More
Congress Can Refocus Attention on Market-Based Solutions to Crack Down on… Read More
Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for… Read More
Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch… Read More
Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite… Read More
Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual… Read More
Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More